연구동향 분석
박사

CXCR7 promotes migration and invasion in head and neck squamous cell carcinoma by upregulating TGF-β1/Smad2/3 signaling

류혜원 2020년

논문상세정보
인용/피인용
' CXCR7 promotes migration and invasion in head and neck squamous cell carcinoma by upregulating TGF-β1/Smad2/3 signaling' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 질병
  • Smad2/3
  • cxcr7
  • epithelial mesenchymal transition
  • head and neck squamous cell carcinoma
  • tgf-β1
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,276 0

0.0%

' CXCR7 promotes migration and invasion in head and neck squamous cell carcinoma by upregulating TGF-β1/Smad2/3 signaling' 의 참고문헌

  • Zhou J. CXCR7 attenuates the TGF-beta-induced endothelial-to-mesenchymal transition and pulmonary fibrosis
    13 ( 10 ) :2116-24 . [2017]
  • Xenograft models of head and neck cancers
    0.0638888888888889 [2009]
  • Van Waes C. The PI3K/Akt/mTOR axis in head and neck cancer : functions , aberrations , cross-talk , and therapies
    21 ( 7 ) :815-25 . [2015]
  • Transforming growth factor-beta1 upregulates the expression of CXC chemokine receptor 4 ( CXCR4 ) in human breast cancer MCF-7 cells .
    31 ( 3 ) :347-54 . [2010]
  • Transforming growth factor-beta signaling in head and neck squamous cell carcinoma : Insights into cellular responses
    16 ( 4 ) :4799-806 . [2018]
  • The roles of TGFbeta in the tumour microenvironment .
    13 ( 11 ) :788-99 . [2013]
  • The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells
    0.467361111 [2011]
  • Struyf S. The role of CXC chemokines and their receptors in cancer
    267 ( 2 ) :226-44 . [2008]
  • Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities
    64 ( 7 ) :2534-43 . [2004]
  • Smad-dependent and Smad-independent pathways in TGF-beta family signalling
    425 ( 6958 ) :577-84 . [2003]
  • Sidransky D. Head and neckCancer
    345 ( 26 ) :1890-900 . [2001]
  • Role ofCXCR4/SDF-1 alpha in the migratory phenotype of hepatomaCells that have undergone epithelial-mesenchymal transition in response to the transforming growth factor-beta
    21 ( 11 ) :1595-606 . [2009]
  • Progressive tumor formation in mice withConditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway
    69 ( 14 ) :5918-26 . [2009]
  • P. The dynamic roles of TGF-beta in cancer
    223 ( 2 ) :205-18 . [2011]
  • P. TGF-beta signalling and its role in cancer progression and metastasis
    31 ( 3-4 ) :553-68 . [2012]
  • New functions for the matrix metalloproteinases in cancer progression
    2 ( 3 ) :161-74 . [2002]
  • Mentlein R. An infernal trio : the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology .
    195 ( 2 ) :103-10 . [2013]
  • Mechanisms of Invasion in Head and Neck Cancer .
    139 ( 11 ) :1334-48 . [2015]
  • Matrix metalloproteases in head and neck cancer
    28 ( 7 ) :639-48 . [2006]
  • Massague J. Betaglycan presents ligand to the TGF beta signaling receptor
    73 ( 7 ) :1435-44 . [1993]
  • Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma ( HNSCC )
    9 ( 4 ) : e94273 . [2014]
  • Kim S. CXC chemokines and chemokine receptors in gastric cancer : from basic findings towards therapeutic targeting
    20 ( 7 ) :1681-93 . [2014]
  • Irimura T. Initial steps in lymph node metastasis formation in an experimental system : possible involvement of recognition by macrophage C-type lectins
    49 ( 1 ) :1-9 . [2000]
  • International Union of Basic and Clinical Pharmacology . . LXXXIX . Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors .
    66 ( 1 ) :1-79 . [2014]
  • Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer
    35 ( 3 ) :221-8 . [2008]
  • Head and neck cancer
    371 ( 9625 ) :1695-709 . [2008]
  • Epithelial-mesenchymal transitions in tumour progression
    2 ( 6 ) :442-54 . [2002]
  • Epithelial-mesenchymal transitions in development and disease
    139 ( 5 ) :871-90 . [2009]
  • Epithelial-mesenchymal transition in cancer development and its clinical significance .
    101 ( 2 ) :293-9 . [2010]
  • Epithelial-mesenchymal transition , the tumor microenvironment , and metastatic behavior of epithelial malignancies .
    3 ( 2 ) :117-36 . [2012]
  • E. Development of a new invasion and metastasis model of human oral squamous cell carcinomas .
    31B ( 4 ) :216-21 . [1995]
  • Dissecting the metastatic cascade .
    4 ( 6 ) :448-56 . [2004]
  • Derynck R. TGF-beta-induced epithelial to mesenchymal transition .
    19 ( 2 ) :156-72 . [2009]
  • Derynck R. TGF-beta-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion .
    125 ( Pt 5 ) :1259-73 . [2012]
  • Chemokine receptor CXCR7 regulates the invasion , angiogenesis and tumor growth of human hepatocellular carcinoma cells
    1.22986111111111 [2010]
  • Chemokine receptor 7 overexpression promotes mesenchymal stem cell migration and proliferation via secreting Chemokine ligand 12 .
    8 ( 1 ) :204 . [2018]
  • Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis .
    14 ( 2 ) :163-76 . [2000]
  • Cabanas C. CXCR7 impact on CXCL12 biology and disease
    19 ( 1 ) :12-22 . [2013]
  • CXCR7 mediates TGFbeta1-promoted EMT and tumor-initiating features in lung cancer .
    35 ( 16 ) :2123-32 . [2016]
  • CXCR7 ( RDC1 ) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature
    104 ( 40 ) :15735-40 . [2007]
  • A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival , cell adhesion , and tumor development
    203 ( 9 ) :2201-13 . [2006]
  • 2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: a cancer journal for clinicians. 2015;65(1):5-29.
    65 ( 1 ) :5-29 . [2015]